{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:10:04Z","timestamp":1790439004138,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,12,6]],"date-time":"2014-12-06T00:00:00Z","timestamp":1417824000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s11095-014-1583-0","type":"journal-article","created":{"date-parts":[[2014,12,8]],"date-time":"2014-12-08T14:42:45Z","timestamp":1418049765000},"page":"1894-1906","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["A Novel Monocarboxylate Transporter Inhibitor as a Potential Treatment Strategy for \u03b3-Hydroxybutyric Acid Overdose"],"prefix":"10.1007","volume":"32","author":[{"given":"Nisha","family":"Vijay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget L.","family":"Morse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn E.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,6]]},"reference":[{"issue":"3","key":"1583_CR1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0301-0082(96)00064-0","volume":"51","author":"M Maitre","year":"1997","unstructured":"Maitre M. The gamma-hydroxybutyrate signalling system in brain: organization and functional implications. Prog Neurobiol. 1997;51(3):337\u201361.","journal-title":"Prog Neurobiol"},{"issue":"1","key":"1583_CR2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2165\/00139709-200423010-00002","volume":"23","author":"CG Wong","year":"2004","unstructured":"Wong CG, Chan KF, Gibson KM, Snead OC. Gamma-hydroxybutyric acid: neurobiology and toxicology of a recreational drug. Toxicol Rev. 2004;23(1):3\u201320.","journal-title":"Toxicol Rev"},{"issue":"6","key":"1583_CR3","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0196-0644(98)70232-X","volume":"31","author":"J Li","year":"1998","unstructured":"Li J, Stokes SA, Woeckener A. A tale of novel intoxication: a review of the effects of gamma-hydroxybutyric acid with recommendations for management. Ann Emerg Med. 1998;31(6):729\u201336.","journal-title":"Ann Emerg Med"},{"issue":"7","key":"1583_CR4","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1553-2712.2002.tb02154.x","volume":"9","author":"PE Mason","year":"2002","unstructured":"Mason PE, Kerns 2nd WP. Gamma hydroxybutyric acid (GHB) intoxication. Acad Emerg Med. 2002;9(7):730\u20139.","journal-title":"Acad Emerg Med"},{"issue":"3","key":"1583_CR5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ajem.2009.11.008","volume":"29","author":"DL Zvosec","year":"2011","unstructured":"Zvosec DL, Smith SW, Porrata T, Strobl AQ, Dyer JE. Case series of 226 gamma-hydroxybutyrate-associated deaths: lethal toxicity and trauma. Am J Emerg Med. 2011;29(3):319\u201332.","journal-title":"Am J Emerg Med"},{"issue":"4","key":"1583_CR6","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF00265954","volume":"45","author":"P Palatini","year":"1993","unstructured":"Palatini P, Tedeschi L, Frison G, Padrini R, Zordan R, Orlando R, et al. Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers. Eur J Clin Pharmacol. 1993;45(4):353\u20136.","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"1583_CR7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0022-3565(25)31515-6","volume":"208","author":"JT Lettieri","year":"1979","unstructured":"Lettieri JT, Fung HL. Dose-dependent pharmacokinetics and hypnotic effects of sodium gamma-hydroxybutyrate in the rat. J Pharmacol Exp Ther. 1979;208(1):7\u201311.","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"1583_CR8","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/jps.2600690331","volume":"69","author":"C Arena","year":"1980","unstructured":"Arena C, Fung HL. Absorption of sodium gamma-hydroxybutyrate and its prodrug gamma-butyrolactone: relationship between in vitro transport and in vivo absorption. J Pharm Sci. 1980;69(3):356\u20138.","journal-title":"J Pharm Sci"},{"issue":"3","key":"1583_CR9","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1124\/jpet.105.083253","volume":"313","author":"ME Morris","year":"2005","unstructured":"Morris ME, Hu K, Wang Q. Renal clearance of gamma-hydroxybutyric acid in rats: increasing renal elimination as a detoxification strategy. J Pharmacol Exp Ther. 2005;313(3):1194\u2013202.","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"1583_CR10","first-page":"425","volume":"13","author":"J Lettieri","year":"1976","unstructured":"Lettieri J, Fung HL. Absorption and first-pass metabolism of 14C-gamma-hydroxybutyric acid. Res Commun Chem Pathol Pharmacol. 1976;13(3):425\u201337.","journal-title":"Res Commun Chem Pathol Pharmacol"},{"issue":"2","key":"1583_CR11","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1124\/jpet.106.105965","volume":"318","author":"Q Wang","year":"2006","unstructured":"Wang Q, Darling IM, Morris ME. Transport of gamma-hydroxybutyrate in rat kidney membrane vesicles: role of monocarboxylate transporters. J Pharmacol Exp Ther. 2006;318(2):751\u201361.","journal-title":"J Pharmacol Exp Ther"},{"issue":"Pt 2","key":"1583_CR12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1042\/0264-6021:3430281","volume":"343","author":"AP Halestrap","year":"1999","unstructured":"Halestrap AP, Price NT. The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem J. 1999;343(Pt 2):281\u201399.","journal-title":"Biochem J"},{"issue":"1","key":"1583_CR13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1208\/s12248-008-9022-y","volume":"10","author":"V Ganapathy","year":"2008","unstructured":"Ganapathy V, Thangaraju M, Gopal E, Martin PM, Itagaki S, Miyauchi S, et al. Sodium-coupled monocarboxylate transporters in normal tissues and in cancer. AAPS J. 2008;10(1):193\u20139.","journal-title":"AAPS J"},{"issue":"43","key":"1583_CR14","doi-asserted-by":"crossref","first-page":"44522","DOI":"10.1074\/jbc.M405365200","volume":"279","author":"E Gopal","year":"2004","unstructured":"Gopal E, Fei YJ, Sugawara M, Miyauchi S, Zhuang L, Martin P, et al. Expression of slc5a8 in kidney and its role in Na(+)-coupled transport of lactate. J Biol Chem. 2004;279(43):44522\u201332.","journal-title":"J Biol Chem"},{"issue":"6","key":"1583_CR15","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s11095-006-9228-6","volume":"24","author":"Q Wang","year":"2007","unstructured":"Wang Q, Lu Y, Morris ME. Monocarboxylate transporter (MCT) mediates the transport of gamma-hydroxybutyrate in human kidney HK-2 cells. Pharm Res. 2007;24(6):1067\u201378.","journal-title":"Pharm Res"},{"issue":"7","key":"1583_CR16","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1124\/dmd.109.027169","volume":"37","author":"D Cui","year":"2009","unstructured":"Cui D, Morris ME. The drug of abuse gamma-hydroxybutyrate is a substrate for sodium-coupled monocarboxylate transporter (SMCT) 1 (SLC5A8): characterization of SMCT-mediated uptake and inhibition. Drug Metab Dispos. 2009;37(7):1404\u201310.","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"1583_CR17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1124\/dmd.106.012369","volume":"35","author":"Q Wang","year":"2007","unstructured":"Wang Q, Morris ME. Flavonoids modulate monocarboxylate transporter-1-mediated transport of gamma-hydroxybutyrate in vitro and in vivo. Drug Metab Dispos. 2007;35(2):201\u20138.","journal-title":"Drug Metab Dispos"},{"issue":"11","key":"1583_CR18","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1124\/dmd.108.022996","volume":"36","author":"Q Wang","year":"2008","unstructured":"Wang Q, Wang X, Morris ME. Effects of L-lactate and D-mannitol on gamma-hydroxybutyrate toxicokinetics and toxicodynamics in rats. Drug Metab Dispos. 2008;36(11):2244\u201351.","journal-title":"Drug Metab Dispos"},{"key":"1583_CR19","doi-asserted-by":"crossref","unstructured":"Morris ME, Morse BL, Baciewicz GJ, Tessena MM, Acquisto NM, Hutchinson DJ, DiCenzo R. Monocarboxylate transporter inhibition with osmotic diuresis increases \u03b3-hydroxybutyrate renal elimination in humans: a proof-of-concept study. J Clinic Toxicol. 2011;1(2):1000105.","DOI":"10.4172\/2161-0495.1000105"},{"issue":"3","key":"1583_CR20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0014-2999(01)01334-6","volume":"428","author":"MA Carai","year":"2001","unstructured":"Carai MA, Colombo G, Brunetti G, Melis S, Serra S, Vacca G, et al. Role of GABA(B) receptors in the sedative\/hypnotic effect of gamma-hydroxybutyric acid. Eur J Pharmacol. 2001;428(3):315\u201321.","journal-title":"Eur J Pharmacol"},{"issue":"10","key":"1583_CR21","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1111\/j.1460-9568.2003.03013.x","volume":"18","author":"K Kaupmann","year":"2003","unstructured":"Kaupmann K, Cryan JF, Wellendorph P, Mombereau C, Sansig G, Klebs K, et al. Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice. Eur J Neurosci. 2003;18(10):2722\u201330.","journal-title":"Eur J Neurosci"},{"issue":"2","key":"1583_CR22","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1124\/mol.112.078154","volume":"82","author":"BL Morse","year":"2012","unstructured":"Morse BL, Vijay N, Morris ME. gamma-Hydroxybutyrate (GHB)-induced respiratory depression: combined receptor-transporter inhibition therapy for treatment in GHB overdose. Mol Pharmacol. 2012;82(2):226\u201335.","journal-title":"Mol Pharmacol"},{"issue":"1","key":"1583_CR23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1124\/jpet.104.069682","volume":"311","author":"I Bhattacharya","year":"2004","unstructured":"Bhattacharya I, Boje KM. GHB (gamma-hydroxybutyrate) carrier-mediated transport across the blood\u2013brain barrier. J Pharmacol Exp Ther. 2004;311(1):92\u20138.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"1583_CR24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1124\/dmd.111.041749","volume":"40","author":"SA Roiko","year":"2012","unstructured":"Roiko SA, Felmlee MA, Morris ME. Brain uptake of the drug of abuse gamma-hydroxybutyric acid in rats. Drug Metab Dispos. 2012;40(1):212\u20138.","journal-title":"Drug Metab Dispos"},{"issue":"10","key":"1583_CR25","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2174\/13816128113199990462","volume":"20","author":"N Vijay","year":"2014","unstructured":"Vijay N, Morris ME. Role of monocarboxylate transporters in drug delivery to the brain. Curr Pharm Des. 2014;20(10):1487\u201398.","journal-title":"Curr Pharm Des"},{"issue":"5","key":"1583_CR26","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1007\/s11095-013-0973-z","volume":"30","author":"SA Roiko","year":"2013","unstructured":"Roiko SA, Vijay N, Felmlee MA, Morris ME. Brain extracellular gamma-hydroxybutyrate concentrations are decreased by L-lactate in rats: role in the treatment of overdoses. Pharm Res. 2013;30(5):1338\u201348.","journal-title":"Pharm Res"},{"issue":"1","key":"1583_CR27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1432-2277.2012.01579.x","volume":"26","author":"C Pahlman","year":"2013","unstructured":"Pahlman C, Qi Z, Murray CM, Ferguson D, Bundick RV, Donald DK, et al. Immunosuppressive properties of a series of novel inhibitors of the monocarboxylate transporter MCT-1. Transpl Int. 2013;26(1):22\u20139.","journal-title":"Transpl Int"},{"issue":"9","key":"1583_CR28","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1097\/01.tp.0000287541.53389.be","volume":"84","author":"H Ekberg","year":"2007","unstructured":"Ekberg H, Qi Z, Pahlman C, Veress B, Bundick RV, Craggs RI, et al. The specific monocarboxylate transporter-1 (MCT-1) inhibitor, AR-C117977, induces donor-specific suppression, reducing acute and chronic allograft rejection in the rat. Transplantation. 2007;84(9):1191\u20139.","journal-title":"Transplantation"},{"issue":"3","key":"1583_CR29","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1042\/BJ20091515","volume":"425","author":"MJ Ovens","year":"2010","unstructured":"Ovens MJ, Davies AJ, Wilson MC, Murray CM, Halestrap AP. AR-C155858 is a potent inhibitor of monocarboxylate transporters MCT1 and MCT2 that binds to an intracellular site involving transmembrane helices 7\u201310. Biochem J. 2010;425(3):523\u201330.","journal-title":"Biochem J"},{"issue":"3","key":"1583_CR30","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1124\/jpet.109.165381","volume":"333","author":"MA Felmlee","year":"2010","unstructured":"Felmlee MA, Roiko SA, Morse BL, Morris ME. Concentration-effect relationships for the drug of abuse gamma-hydroxybutyric acid. J Pharmacol Exp Ther. 2010;333(3):764\u201371.","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"1583_CR31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-0404.2006.00712.x","volume":"114","author":"KR Drasbek","year":"2006","unstructured":"Drasbek KR, Christensen J, Jensen K. Gamma-hydroxybutyrate\u2013a drug of abuse. Acta Neurol Scand. 2006;114(3):145\u201356.","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"1583_CR32","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1124\/dmd.108.025544","volume":"37","author":"Y Shitara","year":"2009","unstructured":"Shitara Y, Nagamatsu Y, Wada S, Sugiyama Y, Horie T. Long-lasting inhibition of the transporter-mediated hepatic uptake of sulfobromophthalein by cyclosporin a in rats. Drug Metab Dispos. 2009;37(6):1172\u20138.","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"1583_CR33","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1124\/jpet.112.202796","volume":"345","author":"BL Morse","year":"2013","unstructured":"Morse BL, Morris ME. Effects of monocarboxylate transporter inhibition on the oral toxicokinetics\/toxicodynamics of gamma-hydroxybutyrate and gamma-butyrolactone. J Pharmacol Exp Ther. 2013;345(1):102\u201310.","journal-title":"J Pharmacol Exp Ther"},{"issue":"9","key":"1583_CR34","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/BF00965839","volume":"16","author":"EE Kaufman","year":"1991","unstructured":"Kaufman EE, Nelson T. An overview of gamma-hydroxybutyrate catabolism: the role of the cytosolic NADP(+)-dependent oxidoreductase EC 1.1.1.19 and of a mitochondrial hydroxyacid-oxoacid transhydrogenase in the initial, rate-limiting step in this pathway. Neurochem Res. 1991;16(9):965\u201374.","journal-title":"Neurochem Res"},{"issue":"1 Pt 1","key":"1583_CR35","first-page":"E207","volume":"273","author":"DZ Gerhart","year":"1997","unstructured":"Gerhart DZ, Enerson BE, Zhdankina OY, Leino RL, Drewes LR. Expression of monocarboxylate transporter MCT1 by brain endothelium and glia in adult and suckling rats. Am J Physiol. 1997;273(1 Pt 1):E207\u201313.","journal-title":"Am J Physiol"},{"issue":"1","key":"1583_CR36","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1124\/dmd.111.041285","volume":"40","author":"BL Morse","year":"2012","unstructured":"Morse BL, Felmlee MA, Morris ME. gamma-Hydroxybutyrate blood\/plasma partitioning: effect of physiologic pH on transport by monocarboxylate transporters. Drug Metab Dispos. 2012;40(1):64\u20139.","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"1583_CR37","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/emj.2008.068403","volume":"28","author":"M Galicia","year":"2011","unstructured":"Galicia M, Nogue S, Miro O. Liquid ecstasy intoxication: clinical features of 505 consecutive emergency department patients. Emerg Med J. 2011;28(6):462\u20136.","journal-title":"Emerg Med J"},{"issue":"3","key":"1583_CR38","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1124\/jpet.113.206250","volume":"346","author":"BL Morse","year":"2013","unstructured":"Morse BL, Morris ME. Toxicokinetics\/toxicodynamics of gamma-hydroxybutyrate-ethanol intoxication: evaluation of potential treatment strategies. J Pharmacol Exp Ther. 2013;346(3):504\u201313.","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"1583_CR39","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1124\/dmd.109.030775","volume":"38","author":"WK Lam","year":"2010","unstructured":"Lam WK, Felmlee MA, Morris ME. Monocarboxylate transporter-mediated transport of gamma-hydroxybutyric acid in human intestinal Caco-2 cells. Drug Metab Dispos. 2010;38(3):441\u20137.","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"1583_CR40","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1208\/s12248-014-9593-8","volume":"16","author":"BA Morse","year":"2014","unstructured":"Morse BA, Vijay N, Morris ME. Mechanistic modeling of Monocarboxylate transporter-mediated toxicokinetic\/toxicodynamic interactions between \u03b3-hydroxybutyrate and L-lactate. AAPS J. 2014;16(4):756\u201370.","journal-title":"AAPS J"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-014-1583-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-014-1583-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-014-1583-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T23:41:59Z","timestamp":1747179719000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-014-1583-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["1583"],"URL":"https:\/\/doi.org\/10.1007\/s11095-014-1583-0","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,6]]}}}